相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)
Marcel Levi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2007)
Evaluating the use of Drotrecogin alfa (activated) in adult severe sepsis: a Canadian multicenter observational study
Salmaan Kanji et al.
INTENSIVE CARE MEDICINE (2007)
Use of Drotrecogin alfa (activated) in Italian intensive care units: the results of a nationwide survey
Guido Bertolini et al.
INTENSIVE CARE MEDICINE (2007)
Dyotyecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment
JL Vincent et al.
CRITICAL CARE MEDICINE (2005)
Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death
E Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Recombinant human activated protein C in sepsis: Inconsistent trial results, an unclear mechanism of action, and safety concerns resulted in labeling restrictions and the need for phase IV trials
PQ Eichacker et al.
CRITICAL CARE MEDICINE (2003)
Drotrecogin alfa (activated) (recombinant human activated protein C) for the treatment of severe sepsis
GR Bernard
CRITICAL CARE MEDICINE (2003)
Efficacy and safety of recombinant human activated protein C for severe sepsis.
GR Bernard et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)